Gyomor- és nyelőcsőrák trials, also abroad
1483 open Gyomor- és nyelőcsőrák trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
| Ország | Open trials |
|---|---|
| Kína | 724 |
| Egyesült Államok | 274 |
| Franciaország | 80 |
| Olaszország | 71 |
| Spanyolország | 64 |
| All other countries |
The same trial often runs in several countries
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer has 5 sites in Dél-Korea and runs in 28 countries. If a site near you is full, another one may still take people.
See A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer in all 28 countries